FDA Removes Marketing Limits on Diabetes Drug Avandia

The FDA, in a U-turn from its position three years ago, removed the restrictions it imposed on the sale of GlaxoSmithKline's diabetes drug Avandia.



from WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304465604579220271002055140.html?mod=pls_whats_news_us_business_f

via IFTTT